ZFIN ID: ZDB-FISH-150901-11230
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.
Fish name: npas4lDf(Chr13:lycat)m39/m39
Genotype: npas4lDf(Chr13:lycat)m39/m39
Targeting Reagent: none
HUMAN DISEASE MODELED by npas4lDf(Chr13:lycat)m39/m39
No data available
GENE EXPRESSION
Gene expression in npas4lDf(Chr13:lycat)m39/m39
RNA expression
Expressed Gene Structure Conditions Figures
etv2 standard conditions Fig. S4 from Reischauer et al., 2016
Fig. 6 from Li et al., 2014
fgf10a standard conditions Fig. 6 with image from Wilfinger et al., 2013
fgf24 standard conditions Fig. 6 with image from Wilfinger et al., 2013
fli1a standard conditions Fig. 1 from Xiong et al., 2008
gata1a standard conditions Fig. 1 from Mahony et al., 2016
Fig. S4 from Reischauer et al., 2016
Fig. 6 from Oates et al., 1999
gc standard conditions Fig. 4 with image from Noël et al., 2010
hbae1.1 control Fig. 6 from Oates et al., 1999
hbbe3 control Fig. 6 from Oates et al., 1999
jak2a control Fig. 6, Table 1 from Oates et al., 1999
kdrl control Fig. 7 from Craig et al., 2015
lcp1 amputation Fig. 5 with image from Yoshinari et al., 2009
ltbp3 standard conditions Fig. S3 from Zhou et al., 2011
meis3 standard conditions Fig. 6 with image from Wilfinger et al., 2013
mmp9 amputation Fig. 5 with image from Yoshinari et al., 2009
mpx amputation Fig. 5 with image from Yoshinari et al., 2009
nfatc1 standard conditions Fig. 1 with image from Wong et al., 2012
oxt standard conditions Fig. 5 with image from Gutnick et al., 2011
pku300 standard conditions Fig. 2 with image from Wang et al., 2013
sox7 standard conditions Fig. S2 from Herpers et al., 2008
sox18 standard conditions Fig. S2 from Herpers et al., 2008
tal1 standard conditions Fig. S4 from Reischauer et al., 2016
Fig. 6 from Li et al., 2014
Fig. 6, Fig. 7 from Oates et al., 1999
tbxta standard conditions Fig. S1 with image from Novikov et al., 2013
tfec standard conditions Fig. 1 from Mahony et al., 2016
tmem88a standard conditions Fig. S1 with image from Novikov et al., 2013
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab2-oxt oxt standard conditions Fig. 5 with image from Gutnick et al., 2011
Reporter gene expression No data available
PHENOTYPE
Phenotype in npas4lDf(Chr13:lycat)m39/m39
Phenotype Conditions Figures
blood island tfec expression absent, abnormal standard conditions Fig. 1 from Mahony et al., 2016
blood island gata1a expression absent, abnormal standard conditions Fig. 1 from Mahony et al., 2016
blood vasculature morphology, abnormal standard conditions Fig. S2 from Herpers et al., 2008
blood vessel morphogenesis disrupted, abnormal standard conditions Fig. S2 from Herpers et al., 2008
cell aging magnitude, normal standard conditions Fig. 3 with image from Kishi et al., 2008
endocardium development disrupted, abnormal standard conditions Fig. 1 with image from Wong et al., 2012
eye lens opaque, abnormal standard conditions Fig. 1 from Zou et al., 2015
fin regeneration occurrence, normal standard conditions Fig. 6 with image from Yoshinari et al., 2009
hematopoietic system jak2a expression absent, abnormal control Table 1 from Oates et al., 1999
intermediate cell mass of mesoderm jak2a expression absent, abnormal control Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm etv2 expression decreased amount, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm hbae1.1 expression decreased amount, abnormal control Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm hbbe3 expression decreased amount, abnormal control Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm tal1 expression decreased amount, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
Fig. 6, Fig. 7 from Oates et al., 1999
intermediate cell mass of mesoderm gata1a expression decreased distribution, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm etv2 expression decreased distribution, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm tal1 expression decreased distribution, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm decreased size, abnormal standard conditions Fig. S4 from Reischauer et al., 2016
lateral plate mesoderm tal1 expression absent, abnormal control Fig. 7 from Oates et al., 1999
lens enucleation decreased occurrence, abnormal standard conditions Fig. 6 from Wu et al., 2016
neurohypophysis has normal numbers of parts of type neurosecretory neuron axon terminus, normal standard conditions Fig. 5 with image from Gutnick et al., 2011
neurohypophysis lacks all parts of type blood vasculature, abnormal standard conditions Fig. 5 with image from Gutnick et al., 2011
pericardium edematous, abnormal standard conditions Fig. S2 from Herpers et al., 2008
posterior lateral plate mesoderm physical object quality, abnormal standard conditions Fig. S1 with image from Novikov et al., 2013
whole organism lacks all parts of type endothelial cell, abnormal standard conditions Fig. S3 from Zhou et al., 2011

CITATIONS  (26)